Crestor is prescribed to treat high or unhealthy cholesterol levels, as these may lead to dangerous cardiovascular problems like heart attack or stroke. Triglycerides are a kind of fat. This leads to ...
LONDON, Sept 2 (Reuters) - AstraZeneca's key cholesterol drug Crestor has failed to beat Pfizer's Lipitor in a head-to-head clinical study, limiting any boost the British company will get as its U.S.
In a head-to-head test of two popular cholesterol-lowering statin drugs — Lipitor and Crestor — both medications worked equally well. Lipitor (atorvastatin) and Crestor (rosuvastatin) both effectively ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback